Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib.
Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib
Each component has a specific meaning:
Note: Interpret the cml euro score result against the thresholds and context described above.
Enter the basophil percentage, spleen size for the scenario you are assessing. Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib. Use the cml euro score result to inform your calculation.